CTMX
#2673
CytomX Therapeutics, Inc. - Common Stock
3.4 2 USD
+0.03%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+3.01%
Variación mensual
+5.88%
Variación en los últimos 6 meses
-34.10%
Cambio anual
+65.22%
Cierres anteriores
3.3 2
Open
3.4 2
Mínimo
3.4 2
Máximo
3.4 2
Volumen
90
Financials
- Market Capitalization 745.22 M
- Employee 69
- Founded 2008
- CEO N/A
- Website www.cytomx.com
- Headquarter Delaware, United States
- FIGI BBG001J472L3
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-33.83
Relación precio/flujo de caja
7.71
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2656 |  MNPR Monopar Therapeutics Inc. - Common Stock | 113.94 USD | +0.19% | +1.75% | +3.13% | +108.60% | 764.78 M USD | ||
| 2662 |  NGNE Neurogene Inc. - Common Stock | 37.86 USD | -1.43% | -1.43% | +16.17% | +28.69% | 757.63 M USD | ||
| 2674 |  GYRE Gyre Therapeutics, Inc. - Common Stock | 6.68 USD | +0.45% | -5.65% | +13.03% | -19.13% | 744.89 M USD | ||
| 2683 |  BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 9.18 USD | -0.86% | -0.11% | +6.25% | -4.87% | 736.00 M USD |